Geode Capital Management, LLC Talaris Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$2.68 - $3.22 $6,131 - $7,367	-2,288 Reduced 1.1%	205,814 $578,000
Q2 2023 Aug 11, 2023	SELL	$1.78 - $3.2 $356,014 - $640,025	-200,008 Reduced 49.01%	208,102 $632,000
Q1 2023 May 15, 2023	BUY	$1.09 - $2.09 $43,807 - $83,997	40,190 Added 10.92%	408,110 $767,000
Q4 2022 Feb 13, 2023	SELL	$0.94 - $1.64 $5,195 - $9,064	-5,527 Reduced 1.48%	367,920 $375,000
Q3 2022 Nov 14, 2022	BUY	$2.3 - $5.03 $223,325 - $488,402	97,098 Added 35.14%	373,447 $982,000
Q2 2022 Aug 12, 2022	BUY	$4.51 - $9.85 $24,737 - $54,027	5,485 Added 2.03%	276,349 $1.25 Million
Q1 2022 May 13, 2022	BUY	$6.89 - $16.56 $172,532 - $414,678	25,041 Added 10.19%	270,864 $2.67 Million
Q4 2021 Feb 11, 2022	BUY	$12.18 - $17.0 $907,263 - $1.27 Million	74,488 Added 43.48%	245,823 $3.76 Million
Q3 2021 Nov 12, 2021	BUY	$11.61 - $15.99 $200,527 - $276,179	17,272 Added 11.21%	171,335 $2.32 Million
Q2 2021 Aug 13, 2021	BUY	$12.25 - $18.61 $1.89 Million - $2.87 Million	154,063 New	154,063 $2.26 Million

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.